Medical science has come a long way since we first discovered vaccines and penicillin. We hear of new and exciting advances in technology and our understanding of diseases every day, but how is that we are still using old first-line treatments for neurological diseases such as Parkinson's and dementia? New treatments do not seem to be making the light of day, instead failing in the final stages of clinical trials. This talk will attempt to address this pertinent but highly understudied aspect of biosciences by looking at how we conduct science, and what we can do to make us better scientists